Janssen’s AdVac® technology

4 years ago 668  
668  
For more than 20 years, Johnson & Johnson has invested in vaccine capabilities. Our approach to the research and development of vaccines fuses a start-up mindset with deep scientific expertise to prevent some of the most life-threatening infectious diseases.

Share on Social:

FacebookPost on XWhatsappLinkedInInstagramEmail
Please log in or register to post comments